Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP254908.RAgsC-Skpp2Rx3cNwnv9_To-54HRVJIsItVaWnsEgR1UE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP254908.RAgsC-Skpp2Rx3cNwnv9_To-54HRVJIsItVaWnsEgR1UE130_assertion type Assertion NP254908.RAgsC-Skpp2Rx3cNwnv9_To-54HRVJIsItVaWnsEgR1UE130_head.
- NP254908.RAgsC-Skpp2Rx3cNwnv9_To-54HRVJIsItVaWnsEgR1UE130_assertion description "[Intratumor administration of IL4-PE has been initiated for the treatment of malignant astrocytoma in a phase I clinical trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254908.RAgsC-Skpp2Rx3cNwnv9_To-54HRVJIsItVaWnsEgR1UE130_provenance.
- NP254908.RAgsC-Skpp2Rx3cNwnv9_To-54HRVJIsItVaWnsEgR1UE130_assertion evidence source_evidence_literature NP254908.RAgsC-Skpp2Rx3cNwnv9_To-54HRVJIsItVaWnsEgR1UE130_provenance.
- NP254908.RAgsC-Skpp2Rx3cNwnv9_To-54HRVJIsItVaWnsEgR1UE130_assertion SIO_000772 10367674 NP254908.RAgsC-Skpp2Rx3cNwnv9_To-54HRVJIsItVaWnsEgR1UE130_provenance.
- NP254908.RAgsC-Skpp2Rx3cNwnv9_To-54HRVJIsItVaWnsEgR1UE130_assertion wasDerivedFrom befree-2016 NP254908.RAgsC-Skpp2Rx3cNwnv9_To-54HRVJIsItVaWnsEgR1UE130_provenance.
- NP254908.RAgsC-Skpp2Rx3cNwnv9_To-54HRVJIsItVaWnsEgR1UE130_assertion wasGeneratedBy ECO_0000203 NP254908.RAgsC-Skpp2Rx3cNwnv9_To-54HRVJIsItVaWnsEgR1UE130_provenance.